Price increases and sales gains helped Eli Lilly and Co. offset declining revenue from its former blockbuster Zyprexa in the fourth quarter, allowing the company to beat analysts' expectations and raise its 2013 profit forecast.
A bill that would certify Indiana therapists who specialize in using music to treat people with autism, Alzheimer's and other conditions is advancing in the General Assembly.
Shares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company in its industry to two key elements of health care reform: the medical device tax and bundled payments.
Marian University’s College of Osteopathic Medicine—only the second medical school in Indiana—will enroll 162 students this fall, about 8 percent more than it planned.
Two years ago, executives at AIT Laboratories “took their eye off the ball,” and watched the company’s business plummet 29 percent in value. Now, after two years of turmoil, the drug-testing lab says it’s poised to return to the double-digit rates of growth that made it a local star.
The Indianapolis-based health insurer earned $464 million, or $1.51 per share, in the fourth quarter, a 38-percent leap from a year ago, and topped analysts’ forecasts by 8 cents per share.
Greenwood-based Elona Biotechnologies Inc., which has been trying to bring a generic version of insulin to market, was declared in default on $8.4 million in incentives from the city of Greenwood.
Dave Reed is president of the Healthcare Business Solutions group inside Bloomington-based Cook Medical Inc. Since 2007, his team of 18 full-time people—aided by about 60 others throughout Cook’s organization—has worked with hospital systems, distributors of medical products and group purchasing organizations to improve the efficiency of the business side of health care and to make sure new products contribute to that efficiency, as well as solving unmet medical needs.
The Indiana Applied Research Enterprise already has received support from John Lechleiter, CEO of Indianapolis-based Eli Lilly and Co., as a place for collaboration between academic and industrial scientists.
The Carmel insurance agency acquired three separate companies in a flurry of activity at the end of the year that will add 17 people to its staff.
Researchers have chosen an experimental drug by Eli Lilly and Co. for a large federally funded study testing whether it's possible to prevent Alzheimer's disease in older people at high risk of developing it.
Roche Diagnostics Corp. in Indianapolis ranks 89th on the magazine’s latest “Best Companies to Work For” list and was the only Indiana-based company selected.
The leader of the nation's largest health insurer warned Thursday not to assume widespread participation from his company in part of health care overhaul's coverage expansion that unfolds later this year.
Democratic lawmakers pushed Wednesday for Indiana to take steps toward implementing the federal health care overhaul that Republicans who control state government have so far rejected.
Hospitals across Indiana announced restrictions on visitors Wednesday in hopes of preventing the spread of flu, which has claimed the lives of 27 people in the state this season.
You might remember seeing Elroy Jetson sitting in front of a television in the Jetson home, with Astro, his trusty dog, and Jane, his mother, at his side, while the doctor appeared on the screen providing medical care to Elroy. This scene is no longer so futuristic.
A portion of the Patient Protection and Affordable Care Act requiring companies in 2014 to begin offering health insurance to more workers is causing a lot of anxiety.
Ten of Indiana’s largest employers—including the state of Indiana; Cummins Inc.; CNO Financial Group Inc.; Indiana, Purdue and Butler universities; and Indiana University Health—think they have hit upon a solution.
European regulators approved the use of an imaging agent from Eli Lilly and Co., which can help doctors diagnose Alzheimer's disease.
WellPoint Inc. is still considering former Amerigroup Corp. CEO James Carlson among several finalists to become CEO. Statements and filings this month have fueled speculation among analysts and shareholders that Carlson has vaulted ahead of other prospects.
